OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2021
(5)
2022
(4)
2023
(3)
2025
(2)
2017
(2)
2018
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Not available
S-EPMC5455690
|
biostudies-literature
Cite
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.
Not available
S-EPMC8592546
|
biostudies-literature
Cite
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment.
Not available
S-EPMC10326475
|
biostudies-literature
Cite
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A.
Not available
S-EPMC8265963
|
biostudies-literature
Cite
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Not available
S-EPMC6105323
|
biostudies-literature
Cite
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.
Not available
S-EPMC12305539
|
biostudies-literature
Cite
Reproducibility in the absence of selective reporting: An illustration from large-scale brain asymmetry research.
Not available
S-EPMC8675427
|
biostudies-literature
Cite
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Not available
S-EPMC3827771
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets